STOCK TITAN

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags

Numinus Wellness (TSX: NUMI, OTCQB: NUMIF) has achieved a significant milestone as its Psychedelic-Assisted Therapy Training Program received official approval from Colorado state under the Natural Medicine Health Act (Proposition 122). This certification enables the company to train licensed professionals in providing psilocybin services.

The comprehensive certification pathway includes coursework in psychedelic-assisted therapy fundamentals, psilocybin-specific training, trauma-informed care, and practical applications. Healthcare practitioners, including therapists, social workers, and medical professionals, can enroll through an online application process, complete required courses, undergo supervised practicum in Colorado, and pass a final certification exam.

In a corporate update, Numinus disclosed that it has submitted all required information for its year-end financial audit and is working with auditors to complete the process and lift the current cease trade order.

Loading...
Loading translation...

Positive

  • Received state certification in Colorado for psychedelic therapy training program, expanding market presence
  • Program approval positions company to generate revenue from healthcare practitioner training

Negative

  • Company currently under cease trade order pending completion of financial audit

News Market Reaction 1 Alert

+4.71% News Effect

On the day this news was published, NUMIF gained 4.71%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, is proud to announce that its Psychedelic-Assisted Therapy Training Program has been officially approved by the state of Colorado, marking a significant milestone in the company's mission to expand safe and effective psychedelic-assisted therapy. This approval comes as part of Colorado's Natural Medicine Health Act (Proposition 122), which establishes a legal framework for the facilitation of psilocybin services by trained and licensed professionals.

"This is an exciting step forward for both Numinus and for the future of psychedelic-assisted therapy in Colorado," said Michael Tan, CEO of Numinus Wellness. "We are committed to ensuring that practitioners receive the highest standard of training so they can provide safe, ethical, and transformative psilocybin-assisted therapy in accordance with Colorado's regulations."

Numinus' state-approved certification pathway includes coursework in psychedelic-assisted therapy fundamentals, psilocybin-specific training, trauma-informed care, and practical applications, along with clinical practicum placements to ensure hands-on experience.

"Our program is designed to go beyond the basics, offering experiential learning, trauma-informed care, and somatic practices that prepare facilitators for the nuances of psychedelic-assisted therapy," said Amanda Giesler, Director of Training at Numinus. "By completing our certification, practitioners can enter this field with the knowledge, skills, and ethical grounding to provide safe and impactful care."

The certification pathway is open to various healthcare practitioners, including therapists, social workers, and medical professionals. Applicants submit an online form, enroll in required courses, complete a supervised practicum in Colorado, and pass a final certification exam. Those interested in joining the program can visit numinus.com/training or contact training@numinus.com for more information.

Corporate Update: Year-End Financial Audit & Q1 Review

Numinus has submitted all required information for its year-end financial audit and continues to work diligently with auditors to complete the process. The company remains focused on finalizing its financials and lifting the current cease trade order as soon as possible.

About Numinus

Numinus Wellness Inc. (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus' clinical trial research and comprehensive practitioner training programs are at the forefront of a transformation aimed at healing rather than managing symptoms of depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedInFacebook, and Instagram.

Forward-looking statements

Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect", and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements, and other risks that are set forth in our annual information form dated November 29, 2023, and available on SEDAR at www.sedarplus.ca. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. Numinus does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/numinus-approved-as-a-state-certified-natural-medicine-training-program-in-colorado-302406698.html

SOURCE Numinus Wellness Inc.

FAQ

What does Colorado's approval mean for Numinus (NUMIF) Psychedelic-Assisted Therapy Program?

The approval allows Numinus to provide state-certified training for licensed professionals to conduct psilocybin services under Colorado's Natural Medicine Health Act.

What are the requirements for healthcare practitioners to complete Numinus's certification program?

Practitioners must submit an online application, complete required coursework, undergo supervised practicum in Colorado, and pass a final certification exam.

What is the current status of Numinus's (NUMIF) financial audit?

The company has submitted all required information and is working with auditors to complete the year-end financial audit and lift the cease trade order.

What components are included in Numinus's Colorado-approved training program?

The program includes psychedelic-assisted therapy fundamentals, psilocybin-specific training, trauma-informed care, practical applications, and clinical practicum placements.
Numinus Wellness Inc.

OTC:NUMIF

NUMIF Rankings

NUMIF Latest News

NUMIF Stock Data

11.74M
314.99M
3.5%
2.83%
Medical Care Facilities
Healthcare
Link
Canada
Vancouver